|
Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR study |
|
|
|
Title: |
Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR study |
Author: |
André, T. Tournigand, C. Mineur, L. Fellague-Chebra, R. Flesch, M. Mabro, M. Hebbar, M. Postel Vinay, S. Bidard, F.C. Louvet, C. de Gramont, A. |
Appeared in: |
Annals of oncology |
Paging: |
Volume 18 () nr. 1 pages 77-81 |
Year: |
2007 |
Contents: |
|
Publisher: |
European Society for Medical Oncology |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|